Skip to content
Open in App
Johnson Johnson logo

Johnson Johnson

web2

Johnson & Johnson, together with its subsidiaries, engages in the research and development, man...

Symbol · JNJUS
Company profile

About

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.

Explore by sector

Explore this sector

Presentation

Watch Johnson Johnson

Market identity

Exchange listings

Listing identities only. Orbitrum does not publish live prices or market performance on this public profile.

Progress

Roadmap

Finalisation de l'acquisition d'Intra-Cellular Therapies

KEY STEP

Johnson & Johnson a finalisé l'acquisition d'Intra-Cellular Therapies, intégrant notamment CAPLYTA et un pipeline clinique en neurosciences à son activité Innovative Medicine.

Roadmap reference
People

Company team

MA

Mark Alan Weinberger

Independent Director

Company leadership profile.

JD

Joaquin Duato

CEO & Chairman

Company leadership profile.

MA

Marillyn A. Hewson

Lead Independent Director

Company leadership profile.

HJ

Hubert Joly

Independent Director

Company leadership profile.

EA

Eugene A. Woods

Independent Director

Company leadership profile.

MB

Mark B. McClellan

Independent Director

Company leadership profile.

MC

Mary C. Beckerle

Independent Director

Company leadership profile.

JA

Jennifer A. Doudna

Independent Director

Company leadership profile.

NY

Nadja Y. West

Independent Director

Company leadership profile.

PA

Paula A. Johnson

Independent Director

Company leadership profile.

DE

Daniel Eduardo Pinto

Director

Company leadership profile.

JG

John G. Morikis

Director

Company leadership profile.

Expert coverage

3 experts evaluated Johnson Johnson.

Orbitrum research

Experts evaluating Johnson Johnson

Explore the public profiles of experts who have evaluated this project.

Orbitrum Academy

Learn how to read a project assessment